Compare UBC Medical Indonesia Tbk. (LABS) vs Mizuho Leasing Indonesia Tbk. (VRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UBC Medical Indonesia Tbk. vs Mizuho Leasing Indonesia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume), while Mizuho Leasing Indonesia Tbk. trades at Rp75 (market cap 426.55B, 34.9K 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 34.9K). Which is the better fit depends on your goals.
| LABS | VRNA | |
|---|---|---|
Market Cap | 635.95B | 426.55B |
Volume | 843K | 34.9K |
Lot | 8.43K | 349 |
Turnover | 137.6M | 2.6M |
Average Price | 163.22 | 74.58 |
Value | 137.6M | 2.6M |
Indicative Equilibrium Price | 165 | — |
Indicative Equilibrium Volume | 246 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →About Mizuho Leasing Indonesia Tbk.
PT Verena Oto Finance (the Company) was established under its original name of PT Maxima Perdana Finance base on notarial deed No.43 of Mrs Sri Nanning, S.H, dated on Jul 21, 1993. The Companys articles of association has been amended several times, most recently by notarial deed No. 32 of Fathiah Helmi, S.H., dated Mar 26, 2007, concerning among others, the change in the Companys name, increase authorized, change in par value, and increase paid-up capital.
Read more on VRNA →
